Arcus Biosciences, Inc. (RCUS)

21.91 +0.38 (+1.76%) USD  |  NYSE  |  Dec 15, 16:00
21.85 -0.06 (-0.27%) Pre-Market: 05:16
More

Arcus Biosciences Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for RCUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Actinium Pharmaceuticals, Inc. Upgrade
Merck & Co., Inc. Upgrade
AbbVie, Inc. Upgrade
Karyopharm Therapeutics, Inc. Upgrade